🔗 Share this article

As America undertakes sweeping changes to its vaccine guidelines, a particular individual has emerged unexpectedly: Dr. Tracy Beth Høeg, an American of Danish descent sports medicine doctor and public health researcher who rose to prominence by questioning Covid vaccinations in the global health crisis and has concentrated on alleged deaths following COVID-19 vaccination in her short position at the FDA.

Scheduled Changes to Pediatric Immunization Schedule

Public health authorities planned to announce major changes to the childhood vaccination calendar in December, aligning the US with Denmark’s vaccine program, it is understood – a significant shift that would place the US out of alignment with many the international standard with little proof for benefit. The announcement has been postponed until the new year.

In place of Vinay Prasad, Tracy Beth Høeg is scheduled to present at the meeting. She was newly appointed temporary leader of the FDA’s drug evaluation center, the fifth person to lead the division this year.

Consolidating Power at the Regulatory Body

This interim role could signify a strengthened alliance between the pharmaceutical and vaccine branches as Dr. Høeg and Prasad solidify control at the regulatory agency – and it points to a greater focus upon rolling back previously authorized immunizations at the FDA.

Dr. Høeg has frequently advocated for discontinuing specific pediatric vaccine recommendations in the US so as to align more similar to Denmark, a nation with universal health coverage and a population about the population of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on vaccines – traditionally the purview of Dr. Prasad, chief of the FDA’s CBER – instead of medication approval.

Concerns Over Expertise

Høeg has little discernible background in drug development, approval processes or management, which has been typical for previous directors of the CBER. She has served at the FDA as a senior adviser to the agency head and the vaccine center since March.

“It seems she lacks to have the necessary background” for running the CDER, said Dr. Jonathan Howard. “She has not conducted a clinical trial. She is not versed in leading a sizeable institution. She is not an expert in drug approvals.”

Past commissioners of the center would “grasp legal statutes and the research of medication creation”, commented Janet Woodcock. “Objectively, she lacks the sort of resume that previous people who ran CBER have had.”

CDER has an enormous range of responsibilities at the FDA, she emphasized.

“The public just zeroes in on the new drug program, but the off-patent medication office clears thousands of generic medications. There is also a biosimilars division, OTC medication office and more, and all of those need to be looked after,” Woodcock explained. “The area you don’t keep your eye on, that’s the thing that I always told people is going to cause problems.”

Furthermore, a substantial management component to the job, which manages over 5,000 employees. “It’s a enormous administrative position, if you do it right,” Woodcock said.

Official Statement and Controversial Policies

In response to inquiries about Høeg’s credentials and whether this appointment signifies more teamwork among FDA leaders on immunizations, a spokesperson stated that the “concerns are based on inaccurate premises”.

“Her experience aligns with the functions of her job,” the spokesperson said, noting the period Høeg spent advising the FDA commissioner on “pharmaceutical safety and approval science, including computational safety modeling and immunization monitoring”.

As the temporary head, Høeg inherits the commissioner’s new expedited review system, a disputed one-day medication authorization process that apparently worried her former heads. “How are these medications being picked for this fast-track system? Who takes the decisions?” Howard said. “There is a lot of lack of transparency occurring at the agency right now.”

In general, he stated, “the FDA looks to be trending towards more relaxed regulations of all drugs, except for immunizations.”

Documented Track Record on Immunizations

Concerning immunizations, Dr. Høeg has a more established, if problematic, track record, Howard said. She published a analysis using unconfirmed crowd-sourced reports to assess the rate of heart inflammation after COVID-19 vaccination. She advised the state of Florida surgeon general Dr. Joseph Ladapo, who reportedly have altered data to imply COVID-19 vaccinations are riskier than they are.

Part of her “policy goals” for the current federal leadership encompassed altering guidelines for new vaccines and halting “unnecessary” immunizations, she remarked post-election on a podcast. At the agency, Dr. Høeg has reportedly suggested preventing teenage boys from getting Covid vaccines.

“She’s an complete ideologue who starts off with her conclusions and tailors the evidence to fit the evidence in a extremely deceptive, dishonest manner,” Dr. Howard stated.

Gaining Influence and a “Push for Payback”

Høeg aligned with other contrarians, {like|